These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 19286405)
1. Applying linear interaction energy method for binding affinity calculations of podophyllotoxin analogues with tubulin using continuum solvent model and prediction of cytotoxic activity. Alam MA; Naik PK J Mol Graph Model; 2009; 27(8):930-43. PubMed ID: 19286405 [TBL] [Abstract][Full Text] [Related]
2. Applying linear interaction energy method for rational design of noncompetitive allosteric inhibitors of the sarco- and endoplasmic reticulum calcium-ATPase. Singh P; Mhaka AM; Christensen SB; Gray JJ; Denmeade SR; Isaacs JT J Med Chem; 2005 Apr; 48(8):3005-14. PubMed ID: 15828839 [TBL] [Abstract][Full Text] [Related]
3. Oxalone and lactone moieties of podophyllotoxin exhibit properties of both the B and C rings of colchicine in its binding with tubulin. Gupta S; Das L; Datta AB; Poddar A; Janik ME; Bhattacharyya B Biochemistry; 2006 May; 45(20):6467-75. PubMed ID: 16700557 [TBL] [Abstract][Full Text] [Related]
4. Molecular modelling evaluation of the cytotoxic activity of podophyllotoxin analogues. Afroz Alam M; Naik PK J Comput Aided Mol Des; 2009 Apr; 23(4):209-25. PubMed ID: 19052697 [TBL] [Abstract][Full Text] [Related]
5. Linkages in tubulin-colchicine functions: the role of the ring C (C') oxygens and ring B in the controls. Pérez-Ramírez B; Gorbunoff MJ; Timasheff SN Biochemistry; 1998 Feb; 37(6):1646-61. PubMed ID: 9484236 [TBL] [Abstract][Full Text] [Related]
6. Molecular modeling and structure-activity relationship of podophyllotoxin and its congeners. Naik PK; Alam A; Malhotra A; Rizvi O J Biomol Screen; 2010 Jun; 15(5):528-40. PubMed ID: 20460251 [TBL] [Abstract][Full Text] [Related]
7. In silico binding free energy predictability by using the linear interaction energy (LIE) method: bromobenzimidazole CK2 inhibitors as a case study. Bortolato A; Moro S J Chem Inf Model; 2007; 47(2):572-82. PubMed ID: 17381174 [TBL] [Abstract][Full Text] [Related]
8. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204 [TBL] [Abstract][Full Text] [Related]
9. Different kinetic pathways of the binding of two biphenyl analogues of colchicine to tubulin. Dumortier C; Gorbunoff MJ; Andreu JM; Engelborghs Y Biochemistry; 1996 Apr; 35(14):4387-95. PubMed ID: 8605187 [TBL] [Abstract][Full Text] [Related]
10. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease. Sham YY; Chu ZT; Tao H; Warshel A Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821 [TBL] [Abstract][Full Text] [Related]
11. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach. Nguyen TL; McGrath C; Hermone AR; Burnett JC; Zaharevitz DW; Day BW; Wipf P; Hamel E; Gussio R J Med Chem; 2005 Sep; 48(19):6107-16. PubMed ID: 16162011 [TBL] [Abstract][Full Text] [Related]
12. Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs. Kelleher JK Cancer Treat Rep; 1978 Oct; 62(10):1443-7. PubMed ID: 101303 [TBL] [Abstract][Full Text] [Related]
13. Continuum solvation models in the linear interaction energy method. Carlsson J; Andér M; Nervall M; Aqvist J J Phys Chem B; 2006 Jun; 110(24):12034-41. PubMed ID: 16800513 [TBL] [Abstract][Full Text] [Related]
14. Free energy calculations on the binding of colchicine and its derivatives with the alpha/beta-tubulin isoforms. Mane JY; Klobukowski M; Huzil JT; Tuszynski J J Chem Inf Model; 2008 Sep; 48(9):1824-32. PubMed ID: 18712858 [TBL] [Abstract][Full Text] [Related]
15. Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analogues. Kroeger Smith MB; Hose BM; Hawkins A; Lipchock J; Farnsworth DW; Rizzo RC; Tirado-Rives J; Arnold E; Zhang W; Hughes SH; Jorgensen WL; Michejda CJ; Smith RH J Med Chem; 2003 May; 46(10):1940-7. PubMed ID: 12723956 [TBL] [Abstract][Full Text] [Related]
16. An estimation method of binding free energy in terms of ABEEMσπ/MM and continuum electrostatics fused into LIE method. Chen SL; Zhao DX; Yang ZZ J Comput Chem; 2011 Jan; 32(2):338-48. PubMed ID: 20662079 [TBL] [Abstract][Full Text] [Related]
17. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization. Ma Y; Fang S; Li H; Han C; Lu Y; Zhao Y; Liu Y; Zhao C Chem Biol Drug Des; 2013 Jul; 82(1):12-21. PubMed ID: 23786349 [TBL] [Abstract][Full Text] [Related]
18. Alterations of rings B and C of colchicine are cumulative in overall binding to tubulin but modify each kinetic step. Dumortier C; Gorbunoff MJ; Andreu JM; Engelborghs Y Biochemistry; 1996 Dec; 35(49):15900-6. PubMed ID: 8961956 [TBL] [Abstract][Full Text] [Related]
19. Stoichiometric and substoichiometric inhibition of tubulin self-assembly by colchicine analogues. Perez-Ramirez B; Andreu JM; Gorbunoff MJ; Timasheff SN Biochemistry; 1996 Mar; 35(10):3277-85. PubMed ID: 8605164 [TBL] [Abstract][Full Text] [Related]
20. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents. Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]